Archambault, A., Chen, C., Breskin, A., Quek, R. G., Hampp, C., Harnett, J., Sobel, R. E., Nkhoma, E., Asubonteng, J., Green, J., Kaul, M., Kim, E. (2025). Evaluating the safety and effectiveness of cemiplimab in combination with platinum-doublet chemotherapy by demographic characteristics in first-line treatment of advanced non-small cell lung cancer: An ongoing multi-database real world evidence study in US patients.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e20572